摘要 |
Deuterated nucleoside analogs of Formula (I) and the pharmaceutically acceptable salts thereof are provided by this disclosure Formula (I) The variables, e.g., B1, Y, R1, R2, R3, R3', R4, R5, R6, R7, R8, and R9 carry definitions set forth in the disclosure. Compounds of Formula (I) are deuterated at one or more positions and the deuterium enrichment at each deuterated positions is at least 50%. Compounds and salts of Formula (I) are useful for treating viral infections, including HCV infections. |
申请人 |
ACHILLION PHARMACEUTICALS, INC. |
发明人 |
DESHPANDE, MILIND;WILES, JASON ALLAN;HASHIMOTO, AKIHIRO;PHADKE, AVINASH |